Treating BRCA breast cancer with PARP inhibition

Relieving spinal cord compression symptoms with a single radiation treatment

Halving duration of ADT for high risk prostate cancer patients

Nivolumab and ipilimumab for metastatic sarcoma

Dose escalation results of ceritinib and nivolumab for ALK NSCLC

Tivantinib as second line therapy for high-MET HCC

3 or 6 months adjuvant oxaliplatin for colorectal cancer

No link between pregnancy and breast cancer relapse

Pooled analysis of avelumab for metastatic urothelial carcinoma

'Conquer Fear' of disease recurrence

Larotrectinib shows durable efficacy across diverse paediatric and adult cancers

Routine genomic testing is feasible, but only a subset of patients benefit